In this Issue:
Limited vs extensive screening for occult cancer in VTE
Idarucizumab reverses dabigatran anticoagulation
Andexanet alfa reverses apixaban anticoagulation
No benefit of LMWH bridging in AF patients needing warfarin interruption
Catheter-directed thrombolysis in DVT
Anticoagulation in symptomatic distal DVT: Findings from the CACTUS study
Two weeks LMWH sufficient in symptomatic distal DVT: Findings from the TWISTER study
Favourable effect of capalcizumab in reducing microvascular ischaemia in acquired TTP
BAX335 gene therapy promising in haemophilia B
Oral contraceptives safe during anticoagulation
No evidence of benefit for statins in reducing recurrent VTE:
• MEGA follow-up study
• Meta-analysis of phase III trials
Please login below to download this issue (PDF)